Angivas MR 35 mg (Tablet (Modified Release))
Unit Price: ৳ 5.00 (3 x 10: ৳ 150.00)
Strip Price: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Trimetazidine dihydrochloride |
Company | Popular pharmaceuticals ltd |
Indications
- Add-on therapy for stable angina pectoris
- Symptomatic treatment for inadequately controlled angina pectoris
Pharmacology
- Metabolic anti-ischemic agent
- Inhibits fatty acid pathway
- Increases heart's energy production
- Prevents angina pectoris
Dosage & Administration
- Recommended dose: 35mg twice daily or 20mg thrice daily
- Assess treatment benefit after three months
Interaction
- No reported drug interactions
- No interaction with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparation
Contraindications
- Hypersensitivity to active substance or excipients
- Patients with Parkinson’s disease or symptoms, tremors, restless legs movement disorders, severe renal impairment
Side Effects
- Common side effects: dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria, asthenia
Pregnancy & Lactation
- Preferable to avoid use during pregnancy
- Risk to newborns/infants cannot be excluded
- Should not be used during breastfeeding
Precautions & Warnings
- Not curative treatment for angina attacks
- Not an initial treatment for unstable angina pectoris
- Not a treatment for myocardial infarction
Therapeutic Class
- Other Anti-anginal & Anti-ischaemic drugs
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Trangit MR 35 mg (Tablet (Modified Release)) - sandoz-a-novartis-division
- Angitrim MR 35 mg (Tablet (Modified Release)) - globe-pharmaceuticals-ltd
- Anginox MR 35 mg (Tablet (Modified Release)) - general-pharmaceuticals-ltd
- Trangina MR 35 mg (Tablet (Modified Release)) - biopharma-limited
- Vestar MR 35 mg (Tablet (Modified Release)) - healthcare-pharmaceuticals-ltd